Healthcare -
Biotechnology - NASDAQ - US
$ 34.63
-2.7 %
$ 2.58 B
Market Cap
-8.9
P/E
Price Target
Average
114.84%
Revenue Forecast
Estimate
485.93%
EBIT
Estimate
13.87%
Net Income
Estimate
30.74%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
SpringWorks Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SWTX of $74.4 , with forecasts ranging from
a
low of
$50 to a high of $94 .
SWTX Lowest Price Target
Wall Street Target
50 USD
44.38%
SWTX Average Price Target
Wall Street Target
74.4 USD
114.84%
SWTX Highest Price Target
Wall Street Target
94 USD
171.44%
REVENUE FORECAST
Revenue Forecast Chart SWTX
EBIT FORECAST
EBIT Forecast Chart SWTX
NET INCOME FORECAST
Net Income Chart SWTX